ES2195922T3 - Composicion sinergica que comprende derivados de daunorrubicina y compuestos antimetabolitos. - Google Patents

Composicion sinergica que comprende derivados de daunorrubicina y compuestos antimetabolitos.

Info

Publication number
ES2195922T3
ES2195922T3 ES00949297T ES00949297T ES2195922T3 ES 2195922 T3 ES2195922 T3 ES 2195922T3 ES 00949297 T ES00949297 T ES 00949297T ES 00949297 T ES00949297 T ES 00949297T ES 2195922 T3 ES2195922 T3 ES 2195922T3
Authority
ES
Spain
Prior art keywords
daunorububine
antimetabolites
compounds
includes derivatives
synergic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00949297T
Other languages
English (en)
Inventor
Maria Cristina Geroni
Marina Ripamonti
Michele Caruso
Antonino Suarato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia SpA filed Critical Pharmacia Italia SpA
Application granted granted Critical
Publication of ES2195922T3 publication Critical patent/ES2195922T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un producto que contiene una antraciclina alquilante de fórmula Ia o Ib: **(Fórmula)** y un compuesto antimetabolito como preparación combinada para uso simultáneo, separado o secuencial en el tratamiento de tumores.
ES00949297T 1999-07-19 2000-07-10 Composicion sinergica que comprende derivados de daunorrubicina y compuestos antimetabolitos. Expired - Lifetime ES2195922T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9916882.5A GB9916882D0 (en) 1999-07-19 1999-07-19 Antitumor synergistic composition

Publications (1)

Publication Number Publication Date
ES2195922T3 true ES2195922T3 (es) 2003-12-16

Family

ID=10857494

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00949297T Expired - Lifetime ES2195922T3 (es) 1999-07-19 2000-07-10 Composicion sinergica que comprende derivados de daunorrubicina y compuestos antimetabolitos.

Country Status (10)

Country Link
EP (1) EP1200099B1 (es)
JP (1) JP2003504394A (es)
AT (1) ATE241991T1 (es)
AU (1) AU6271100A (es)
DE (1) DE60003189T2 (es)
DK (1) DK1200099T3 (es)
ES (1) ES2195922T3 (es)
GB (1) GB9916882D0 (es)
PT (1) PT1200099E (es)
WO (1) WO2001005382A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114654D0 (en) * 2001-06-15 2001-08-08 Pharmacia & Upjohn Spa Anti-tumor compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853221A (en) * 1980-11-13 1989-08-01 Warner-Lambert Company Method for treating non-small cell lung cancer, head and neck cancers and breast cancer
US5919816A (en) * 1994-11-14 1999-07-06 Bionumerik Pharmaceuticals, Inc. Formulations and methods of reducing toxicity of antineoplastic agents
GB9806324D0 (en) * 1998-03-24 1998-05-20 Pharmacia & Upjohn Spa Antitumour synergetic composition
GB9904387D0 (en) * 1999-02-25 1999-04-21 Pharmacia & Upjohn Spa Antitumour synergistic composition
GB9904386D0 (en) * 1999-02-25 1999-04-21 Pharmacia & Upjohn Spa Antitumour synergistic composition
GB9909925D0 (en) * 1999-04-29 1999-06-30 Pharmacia & Upjohn Spa Combined preparations comprising anthracycline derivatives

Also Published As

Publication number Publication date
DE60003189T2 (de) 2003-12-18
PT1200099E (pt) 2003-08-29
DE60003189D1 (de) 2003-07-10
WO2001005382A1 (en) 2001-01-25
JP2003504394A (ja) 2003-02-04
EP1200099A1 (en) 2002-05-02
WO2001005382A8 (en) 2001-04-12
DK1200099T3 (da) 2003-07-21
EP1200099B1 (en) 2003-06-04
GB9916882D0 (en) 1999-09-22
ATE241991T1 (de) 2003-06-15
AU6271100A (en) 2001-02-05

Similar Documents

Publication Publication Date Title
BR0008453A (pt) Composição sinergìstica anti-tumoral
DZ2614A1 (fr) Compositions pharmaceutiques topiques contenant des dérivés de résorcinol.
AR020345A1 (es) Pirazol-carboxanilidas, procedimiento para su obtencion, composiciones, empleo de dichos compuestos y procedimiento para la lucha contra microorganismos indeseables, y procedimiento para la obtencion de dichas composiciones.
DE69716135T2 (de) In 6-position durch thio substituierte paclitaxele
ATE247470T1 (de) Neue substituierte imidazolverbindungen
BG106586A (en) Pyrazolopyramidines as therapeutic agents
ZA200007222B (en) Glycopeptide derivatives and pharmaceutical compositions containing the same.
BR9908391A (pt) Composição antitumural contendo uma combinação sinergìstica de um derivado de antraciclina com um derivado de camptotecina
RS50682B (sr) Kombinacija kombrestatina i anti-kancer agensa
YU55200A (sh) Supstituisani bisindolmaleimidi za inhibiranje ćelijske proliferacije
CY1106713T1 (el) Συνδυασμενη θεραπεια εναντιον καρκινωματων η οποια περιλαμβανει παραγωγα υποκαταστημενης ακρυλοϋλ δισταμυσινης και αλκυλιωτικους παραγοντες
ATE388960T1 (de) Glykopeptidderivate mit carboxysacchariden
ATE232081T1 (de) Orale zusammensetzung enthaltend perlit
ES2195922T3 (es) Composicion sinergica que comprende derivados de daunorrubicina y compuestos antimetabolitos.
TWI262791B (en) 6-methoxy-2-naphthylacetic acid prodrugs
HK1054506A1 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites
BR0008454A (pt) Composição sinergìstica anti-tumoral
BR0002640A (pt) Uso de simeticona para tratar colite ulcerativa
ES2183543T3 (es) Derivado de tiocolchicosida, su preparacion y su aplicacion en terapeutica.
BR9508521A (pt) Inibição da biossintese de leucotrienos com derivados de uréia
TWI231815B (en) Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents